ArticleCritical care (London, England)2019
Control of respiratory drive by extracorporeal CO
Article in Critical care (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 37 citations in OpenAlex.
- Extracorporeal COCritical care (London, England) · 2026Trial
- Two liberations, two physiological targets: implications of the X-COPD trial.Critical care (London, England) · 2026Article
- ECMO-weaning facilitated by neurally adjusted ventilatory assist (NAVA): a case for principal clarification.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025Article
- Is there still a place for ECCOMedizinische Klinik, Intensivmedizin und Notfallmedizin · 2024Review
- Lung- and diaphragm-protective strategies in acute respiratory failure: an in silico trial.Intensive care medicine experimental · 2024Article
- Dyspnoea in acutely ill mechanically ventilated adult patients: an ERS/ESICM statement.Intensive care medicine · 2024Article
- The level of partial pressure of carbon dioxide affects respiratory effort in COVID-19 patients undergoing pressure support ventilation with extracorporeal membrane oxygenation.BMC anesthesiology · 2024Article
- ERS International Congress 2022: highlights from the Respiratory Intensive Care Assembly.ERJ open research · 2023Review
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump.Journal of translational medicine · 2021Article
- Physiological effects of adding ECCOAnnals of intensive care · 2020Article
- Correlation of Arterial COJournal of clinical medicine · 2020Article
- Dual Carbon Dioxide Capture to Achieve Highly Efficient Ultra-Low Blood Flow Extracorporeal Carbon Dioxide Removal.Annals of biomedical engineering · 2020Article
- ECCO2R and NIV-NAVA for stepwise early weaning in extremely severe COPD patients: a promising solution with details to be defined.Critical care (London, England) · 2020Article
- Clinical Utility of Measuring Inspiratory Neural Drive During Cardiopulmonary Exercise Testing (CPET).Frontiers in medicine · 2020Review
- Low-flow assessment of current ECMO/ECCOCritical care (London, England) · 2019Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVeno-venous extracorporeal CO
methodsA physiological study of the electrical activity of the diaphragm (Edi) response was conducted with varying degrees of extracorporeal CO
resultsTwenty COPD patients (SAPS II 37 ± 5.6, age 57 ± 9 years) treated with vv-ECCO
conclusionsThis study demonstrates for the first time the usefulness of the Edi signal to monitor and guide patients with severe acute exacerbation of COPD on vv-ECCO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.